Flaadt, T.; Ebinger, M.; Schreiber, M.; Ladenstein, R.L.; Simon, T.; Lode, H.N.; Hero, B.; Schuhmann, M.U.; Schäfer, J.; Paulsen, F.;
et al. Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse. J. Clin. Med. 2023, 12, 6196.
https://doi.org/10.3390/jcm12196196
AMA Style
Flaadt T, Ebinger M, Schreiber M, Ladenstein RL, Simon T, Lode HN, Hero B, Schuhmann MU, Schäfer J, Paulsen F,
et al. Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse. Journal of Clinical Medicine. 2023; 12(19):6196.
https://doi.org/10.3390/jcm12196196
Chicago/Turabian Style
Flaadt, Tim, Martin Ebinger, Malin Schreiber, Ruth L. Ladenstein, Thorsten Simon, Holger N. Lode, Barbara Hero, Martin U. Schuhmann, Jürgen Schäfer, Frank Paulsen,
and et al. 2023. "Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse" Journal of Clinical Medicine 12, no. 19: 6196.
https://doi.org/10.3390/jcm12196196
APA Style
Flaadt, T., Ebinger, M., Schreiber, M., Ladenstein, R. L., Simon, T., Lode, H. N., Hero, B., Schuhmann, M. U., Schäfer, J., Paulsen, F., Timmermann, B., Eggert, A., & Lang, P.
(2023). Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse. Journal of Clinical Medicine, 12(19), 6196.
https://doi.org/10.3390/jcm12196196
